The state of California currently has 38 active clinical trials seeking participants for Multiple Sclerosis research studies. These trials are conducted in various cities, including Los Angeles, San Francisco, San Diego and Sacramento.
Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple Sclerosis
NCT05122559
Recruiting
This study evaluates the effectiveness of N-acetyl cysteine (NAC) in the treatment of progressive multiple sclerosis. Half of the patients will receive NAC, while the other half will receive a placebo.
Gender:
All
Ages:
Between 40 years and 70 years
Trial Updated:
03/30/2023
Locations: University of California, San Francisco, San Francisco, California
Conditions: Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive
Register for Updates
Reduced Oligodendrocyte-specific Cytotoxicity and Ofatumumab Treatment
NCT05171972
Recruiting
In this study the investigators wish to test the hypothesis that the repertoire of solutes secreted by leukocytes isolated from patients with relapsing-remitting forms of Multiple Sclerosis (MS) following 6 months of treatment with Ofatumumab (Kesimpta®) will be less toxic to mouse-derived oligodendrocyte lineage cells, grown in a dish, than solutes secreted by the same leukocyte populations prior to treatment with Ofatumumab.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
02/03/2022
Locations: University of Southern California, Los Angeles, California
Conditions: Relapsing Remitting Multiple Sclerosis
Register for Updates